|
Medscape May 19, 2012 (Atlanta, Georgia) — Overall survival is lower in patients with renal cell carcinoma who underwent radical nephrectomy with concurrent ipsilateral adrenalectomy than in patients with the ipsilateral adrenal gland left intact, according to ... and more » |
Feeds
4246 items (4246 unread) in 80 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(32 unread)
Adenoid Cystic Carcinoma
(52 unread)
Adrenal Gland Cancer
(299 unread)
Ampulla Of Vater
(13 unread)
Anal Cancer
(249 unread)
Angiosarcoma
(67 unread)
Appendix Cancer
(33 unread)
Bile Duct Cancer
(369 unread)
Brain and CNS
(1029 unread)
Carcinoid
(134 unread)
Endocrine/Neuroendocrine
(265 unread)
Gall Bladder Cancer
(207 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(30 unread)
Pancreas
(41 unread)
Phyllodes
(17 unread)
PMP and Mucinous Tumors
(16 unread)
Rhabdomyosarcoma
(173 unread)
Sarcoma
(531 unread)
Twitter Pals
(638 unread)
Google - Adrenocortical Carcinoma (16 unread)
-
Adrenalectomy Plus Nephrectomy Linked to Reduced Survival - Medscape
Posted: May 19th, 2012, 9:04am MDT
-
Large-scale study finds treatment standard for rare cancer - HealthCanal.com
Posted: May 16th, 2012, 2:07pm MDT
Large-scale study finds treatment standard for rare cancer
HealthCanal.com
Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with this extremely rare and deadly disease. The consortium – which grew out of an international ...
and more » -
Large-scale Study Finds Treatment Standard for Rare Cancer - HealthNewsDigest.com
Posted: May 16th, 2012, 7:32am MDT
HealthNewsDigest.com
Large-scale Study Finds Treatment Standard for Rare Cancer
HealthNewsDigest.com
By Staff Editor (HealthNewsDigest.com) - Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with this extremely rare and deadly disease.
and more » -
Large-scale study finds treatment standard for rare cancer - University of Michigan Health System News (press release)
Posted: May 16th, 2012, 5:47am MDT
University of Michigan Health System News (press release)
Large-scale study finds treatment standard for rare cancer
University of Michigan Health System News (press release)
Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with this extremely rare and deadly disease. The consortium – which grew out of an international ...
and more » -
Fighting for Coach Moose - Cherry Hill Courier Post
Posted: May 14th, 2012, 11:15pm MDT
Fighting for Coach Moose
Cherry Hill Courier Post
Last month, Musumeci learned the cancer had spread. According to the National Cancer Institute, an adrenocortical carcinoma is a rare tumor that affects only up to 2 persons per one million and is most common in children younger than 5 and adults in ...
-
Marathon to battle cancer - Dandenong Star
Posted: May 10th, 2012, 3:05pm MDT
Marathon to battle cancer
Dandenong Star
The Dandenong woman has thrown her support behind good friend and former co-worker Gervais Serret, who is battling adrenocortical carcinoma, an extremely rare and aggressive cancer. Last year, Katarina dedicated time and effort into writing a ...
-
Combination chemotherapy shows benefits for adrenal cancer patients - Medical Xpress
Posted: May 4th, 2012, 12:29am MDT
Combination chemotherapy shows benefits for adrenal cancer patients
Medical Xpress
Endocrinologists at the University of Birmingham have played a key role in a major international clinical trial which has found that giving a combination of chemotherapy drugs to patients suffering from advanced adrenal cancer can help them to live up ...
and more » -
Combination chemotherapy shows benefits for adrenal cancer patients - HealthCanal.com
Posted: May 3rd, 2012, 1:25pm MDT
Combination chemotherapy shows benefits for adrenal cancer patients
HealthCanal.com
Endocrinologists at the University of Birmingham have played a key role in a major international clinical trial which has found that giving a combination of chemotherapy drugs to patients suffering from advanced adrenal cancer can help them to live up ...
and more » -
Research and Markets: Adrenocortical Carcinoma (Adrenal Cortex Cancer ... - SunHerald.com
Posted: May 3rd, 2012, 12:40pm MDT
Research and Markets: Adrenocortical Carcinoma (Adrenal Cortex Cancer ...
SunHerald.com
DUBLIN -- Research and Markets [www.researchandmarkets.com] has announced the addition of Global Markets Direct's new report "Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, ...
and more » -
Mitotane plus Chemo Combo May Benefit Adrenocortical Cancer - MD News (press release)
Posted: May 3rd, 2012, 6:33am MDT
Mitotane plus Chemo Combo May Benefit Adrenocortical Cancer
MD News (press release)
For patients with advanced adrenocortical cancer, mitotane plus a combination of etoposide, doxorubicin, and cisplatin is superior to streptozocin-mitotane for rates of response and progression-free survival, but does not improve overall survival.
and more » -
Mitotane Plus Chemo Combo May Benefit Patients with Adrenocortical Cancer - Renal and Urology News
Posted: May 3rd, 2012, 6:26am MDT
Mitotane Plus Chemo Combo May Benefit Patients with Adrenocortical Cancer
Renal and Urology News
For patients with advanced adrenocortical cancer, mitotane plus a combination of etoposide, doxorubicin, and cisplatin (EDP) is superior to streptozocin-mitotane for rates of response and progression-free survival, but does not improve overall survival ...
and more » -
Combination chemo holds back cancer - Public Service
Posted: May 3rd, 2012, 2:57am MDT
Combination chemo holds back cancer
Public Service
Endocrinologists at the University of Birmingham have found that giving a combination of chemotherapy drugs to patients suffering from advanced adrenal cancer can help them to live up to a fifth longer. According to the New England Journal of Medicine, ...
and more » -
Mixed Results for New Tx in Adrenal Cancer - MedPage Today
Posted: May 2nd, 2012, 4:05pm MDT
Mixed Results for New Tx in Adrenal Cancer
MedPage Today
Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy but had a significantly higher response rate and progression-free survival (PFS). Note that the three-drug combination did ...
and more » -
Mitotane + Chemo Combo May Benefit Adrenocortical Cancer - Doctors Lounge
Posted: May 2nd, 2012, 4:03pm MDT
Mitotane + Chemo Combo May Benefit Adrenocortical Cancer
Doctors Lounge
For patients with advanced adrenocortical cancer, mitotane plus a combination of etoposide, doxorubicin, and cisplatin is superior to streptozocin-mitotane for rates of response and progression-free survival, but does not improve overall survival, ...
and more » -
Holland family looks for second opinion in cancer fight - HollandSentinel.com
Posted: April 7th, 2012, 11:23am MDT
Holland family looks for second opinion in cancer fight
HollandSentinel.com
She said doctors at Helen DeVos Children's Hospital have said his adrenal carcinoma has returned and not much more can be done. Here Jesus is pictured during one hospital stay, when a pet therapy dog visited. By PEG MCNICHOL For two weekends, ...
-
The R337H mutation in TP53 and breast cancer in Brazil - 7thSpace Interactive (press release)
Posted: March 28th, 2012, 4:44am MDT
The R337H mutation in TP53 and breast cancer in Brazil
7thSpace Interactive (press release)
Germline mutations in p53 are associated with the Li-Fraumeni Syndrome which is characterized by childhood cancers, including pediatric adrenal cortical carcinomas and early onset breast cancer. The high incidence of adrenal cortical carcinomas in ...